Sort   by:  
 Page size 
UnknownInhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression.
Not available
S-EPMC4362792 | biostudies-literature
UnknownMicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
Not available
S-EPMC12419200 | biostudies-literature
UnknownSPARCL1 suppresses metastasis in prostate cancer.
Not available
S-EPMC3838491 | biostudies-literature
UnknownRole of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.
Not available
S-EPMC5929166 | biostudies-literature
UnknownIs adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Not available
S-EPMC3589110 | biostudies-literature
Sort   by:  
 Page size